More importantly, multiple studies have drawn a connection between increased RHOA activity and PD-linked phenomena, such as damage of dopaminergic neurons or upregulation of alpha-synuclein (Schmidt S. I. et al., 2022). Here, RHOA is linked to Parkinson disease.